Upcoming Earnings Overview Alcon Inc. is expected to release its latest quarterly earnings on Monday, May 4th, with a consensus EPS estimate of 0.81.
Live Analysis Alcon Inc.'s current price stands at $75.25, showing a decrease of -76.5 cents (-1.01%) from the previous close at $76. The trading volume relative to the average is 12.88%, with a trading volume of $211,924.
Earnings Overview In the most recent quarterly earnings report on Monday, February 23rd, Alcon Inc. surpassed expectations with an EPS of 0.79.
Dividends Alcon Inc. offers a forward dividend yield of 1.23%. The company distributed 33.34 cents per share in the most recent quarter and 56.529 cents over the trailing twelve months.
Cash Flow The company's free cash flow amounts to $489 million, with a net change in cash of $29 million. Alcon Inc. ended the period with $1.53 billion in cash.
Income Statement Alcon Inc. generated $2.72 billion in revenue with a gross profit of $1.47 billion. The company reported a net income of $217 million, resulting in an EPS of 44 cents.
Ratios Key financial metrics show a net profit margin of 8%, return on equity of 0.98, and a price-to-earnings ratio of 44.43.
Balance Sheet Alcon Inc. holds $1.53 billion in cash and cash equivalents, with total assets valued at $31.55 billion and total liabilities at $9.52 billion.
This article provides an overview of Alcon Inc.'s current financial status, including recent performance, upcoming earnings expectations, and key financial metrics.
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.